FDA Faces Scrutiny on Ivermectin While Fast-Tracking Nicotine Pouches

The U.S. Food and Drug Administration (FDA) has entered the spotlight in 2025, facing sharp criticism for what many see as an inconsistent regulatory stance. While the agency accelerates reviews of nicotine pouches—a smokeless tobacco alternative touted as harm reduction—it continues to impose strict caution on ivermectin regulations. This dual approach has...